Skin implant can monitor, transmit glucose levels

03/20/2013 | Medical News Today

Swiss researchers have developed a small, implantable device that can analyze chemical and protein levels and transmit wireless updates. A patch located on top of the skin powers the implant, which can monitor glucose levels in patients with diabetes, warn of impending heart attacks and help determine optimal chemotherapy doses. Research on the device was to be presented at the Design, Automation, and Test in Europe conference.

View Full Article in:

Medical News Today

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX